As determined by ELDA software, the frequency of LSCs was reduced by 47-fold in recipient mice transplanted with VC Phf6,RE9a AML cells as compared with the control mice (Fig. 3F). The gene discussed is PHF6; the disease is acute myeloid leukemia.